Galenica AG
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates in two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at h… Read more
Galenica AG (GALNF) - Total Assets
Latest total assets as of June 2025: $3.06 Billion USD
Based on the latest financial reports, Galenica AG (GALNF) holds total assets worth $3.06 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Galenica AG - Total Assets Trend (2013–2024)
This chart illustrates how Galenica AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Galenica AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Galenica AG's total assets of $3.06 Billion consist of 33.6% current assets and 66.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.2% |
| Accounts Receivable | $460.28 Million | 15.0% |
| Inventory | $363.06 Million | 11.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $224.37 Million | 7.3% |
| Goodwill | $891.48 Million | 29.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Galenica AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Galenica AG's current assets represent 33.6% of total assets in 2024, a decrease from 45.1% in 2013.
- Cash Position: Cash and equivalents constituted 4.2% of total assets in 2024, up from 1.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 28.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 29.0% of total assets.
Galenica AG Competitors by Total Assets
Key competitors of Galenica AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Galenica AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Galenica AG generates 1.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Galenica AG generates $5.96 in net profit.
Galenica AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.29 | 1.33 | 1.37 |
| Quick Ratio | 0.86 | 0.88 | 0.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $243.95 Million | $ 257.26 Million | $ 242.48 Million |
Galenica AG - Advanced Valuation Insights
This section examines the relationship between Galenica AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.09 |
| Latest Market Cap to Assets Ratio | 1.22 |
| Asset Growth Rate (YoY) | 2.7% |
| Total Assets | $3.07 Billion |
| Market Capitalization | $3.75 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Galenica AG's assets above their book value (1.22 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Galenica AG's assets grew by 2.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Galenica AG (2013–2024)
The table below shows the annual total assets of Galenica AG from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.07 Billion | +2.67% |
| 2023-12-31 | $2.99 Billion | +12.29% |
| 2022-12-31 | $2.66 Billion | +1.83% |
| 2021-12-31 | $2.62 Billion | +15.79% |
| 2020-12-31 | $2.26 Billion | +2.23% |
| 2019-12-31 | $2.21 Billion | +18.79% |
| 2018-12-31 | $1.86 Billion | +3.44% |
| 2017-12-31 | $1.80 Billion | -9.44% |
| 2016-12-31 | $1.99 Billion | +14.59% |
| 2015-12-31 | $1.73 Billion | +1.39% |
| 2014-12-31 | $1.71 Billion | -0.98% |
| 2013-12-31 | $1.73 Billion | -- |